| Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1–dependent withdrawal L Deng, J Guindon, BL Cornett, A Makriyannis, K Mackie, AG Hohmann Biological psychiatry 77 (5), 475-487, 2015 | 200 | 2015 |
| The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of … L Deng, J Guindon, VK Vemuri, GA Thakur, FA White, A Makriyannis, ... Molecular pain 8, 1744-8069-8-71, 2012 | 97 | 2012 |
| CB1 knockout mice unveil sustained CB2-mediated antiallodynic effects of the mixed CB1/CB2 agonist CP55, 940 in a mouse model of paclitaxel-induced neuropathic pain L Deng, BL Cornett, K Mackie, AG Hohmann Molecular pharmacology 88 (1), 64-74, 2015 | 66 | 2015 |
| Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture L Deng, L Ng, T Ozawa, N Stella Journal of Pharmacology and Experimental Therapeutics 360 (1), 215-224, 2017 | 61 | 2017 |
| Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and … J Guindon, L Deng, B Fan, J Wager-Miller, AG Hohmann Molecular pain 10, 1744-8069-10-56, 2014 | 59 | 2014 |
| Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery EJ Rahn, L Deng, GA Thakur, K Vemuri, AM Zvonok, YY Lai, ... Molecular pain 10, 1744-8069-10-27, 2014 | 57 | 2014 |
| Inflammatory and neuropathic nociception is preserved in GPR55 knockout mice LM Carey, T Gutierrez, L Deng, WH Lee, K Mackie, AG Hohmann Scientific reports 7 (1), 944, 2017 | 39 | 2017 |
| Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems L Deng, WH Lee, Z Xu, A Makriyannis, AG Hohmann Pharmacological research 114, 75-89, 2016 | 20 | 2016 |
| ABHD6 Controls Amphetamine-Stimulated Hyperlocomotion: Involvement of CB1 Receptors L Deng, K Viray, S Singh, B Cravatt, N Stella Cannabis and Cannabinoid Research 7 (2), 188-198, 2022 | 8 | 2022 |
| Muscarinic agonists in the treatment of neuropathic pain: a novel finding L Deng, J Guindon Clinical and Experimental Pharmacology and Physiology 40 (7), 395-397, 2013 | 2 | 2013 |
| Therapeutic Strategies for Managing the Development and Maintenance of Chemotherapy-induced Neuropathic Pain: A Comparison of Cannabinoids and Clinically Used Analgesics L Deng Indiana University, 2014 | | 2014 |
Ken MackieProfessor Psychological and Brain Sciences, Indiana UniversityDirección de correo verificada de indiana.edu
